Monitor Flashcards
6 cards from real SOCRA CCRP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 Monitor flashcards as text
What is risk-based monitoring (RBM) and why was it introduced in ICH-GCP E6(R2)?
Answer: An approach that focuses monitoring resources on critical data points and processes most likely to affect subject safety and data integrity
Risk-based monitoring focuses monitoring efforts on the most critical aspects of trial conduct. It was introduced in the E6(R2) addendum to improve monitoring effectiveness and efficiency by directing resources to areas of greatest risk to subject protection and data reliability.
What is the purpose of a close-out visit at the end of a clinical trial?
Answer: To ensure all trial activities are completed, documentation is finalized, and site obligations for record retention are communicated
The close-out visit (or site termination visit) ensures that all trial-related activities are properly concluded, outstanding data queries are resolved, essential documents are complete, and the site understands its record retention and post-trial responsibilities.
What should a monitor verify regarding informed consent during routine monitoring visits?
Answer: That consents are properly signed and dated, were obtained before any study procedures, and are the current IRB-approved version
The monitor must verify that each subject's consent form is the current IRB-approved version, properly signed and dated by both the subject and the consenting investigator, and that consent was obtained prior to any study-specific procedures.
What is centralized monitoring and how does it complement on-site monitoring?
Answer: It involves remote evaluation of accumulating data to identify patterns, trends, and anomalies across clinical trial sites
Centralized monitoring involves the remote evaluation of accumulating clinical trial data from all sites, using statistical analyses and data reviews to detect data quality issues, protocol deviations, and safety signals that may not be apparent during individual site visits.
What information must be included in a monitoring visit report?
Answer: The date, site, monitor's name, findings, deviations noted, follow-up actions required, and a summary of key activities performed
ICH-GCP requires that the monitor provide a written report after each site visit that includes the date, site identification, monitor's name, key findings, deviations observed, corrective actions required, and a summary of review activities performed.
What is the monitor's role in managing Corrective and Preventive Actions (CAPAs) at a trial site?
Answer: The monitor identifies issues, recommends corrective actions, verifies implementation, and follows up to prevent recurrence
Monitors play an active role in the CAPA process by identifying compliance issues during visits, collaborating with the site to develop corrective actions, verifying implementation during subsequent visits, and confirming that preventive measures are effective.